The largest database of trusted experimental protocols

3 protocols using apc conjugated anti gr1

1

Murine LAIR-1 Antibody Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies used for this study included: monoclonal anti-murine LAIR-1 antibodies, (Affymetrix/eBioscience, San Diego, Ca) and Armenian hamster IgG isotype control for the anti LAIR-1 (Biolegend, San Diego, Ca). The Abs used for flow cytometry included: PacBlue-conjugated anti-CD4, PE-conjugated anti-IL-2, APC-conjugated anti-IFN-γ, FITC-conjugated anti-CD8, APC-conjugated anti-CD19, FITC-conjugated anti-CD11c, APC-conjugated anti-CD11b, APC-conjugated anti-DX5, APC-conjugated anti-GR-1 (BD Biosciences, San Jose, CA) and PE-conjugated anti-murine LAIR-1 antibodies, (Affymetrix/eBioscience, San Diego, Ca). All were used according to the manufacturer’s recommendations.
+ Open protocol
+ Expand
2

Neutrophil Evaluation After TB Challenge

Check if the same lab product or an alternative is used in the 5 most similar protocols
The neutrophils from the vaccinated animals were evaluated 30 days after the challenge with M. tuberculosis. The splenocytes were obtained as described above. The cells were incubated for 30 min with APC-conjugated anti-GR1 (BD PharMingen), PercP-conjugated anti-CD14, PE-conjugated anti-CD11c and FITC-conjugated anti-CD11b antibodies (eBioscience). Then, the cells were washed with PBS and fixed with paraformaldehyde using Perm Fix (BD Cytofix). A total of 100,000 events were acquired using BD Biosciences FACSVerseTM and analyzed with the FlowJo 9.0 Software. The neutrophils percentage was determined evaluating singlets that were GR-1+, CD11c-, and CD14-. The total number of neutrophils was obtained multiplying the percentage of neutrophils by the total number of splenocytes from each animal.
+ Open protocol
+ Expand
3

Multiparameter Analysis of Murine Hematopoietic Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
WBM was labeled with PB-conjugated anti-B220, PE-conjugated anti-CD4, PE-conjugated anti-CD8, BUV395 conjugated anti-TER 119, APC-conjugated anti-GR1 (BD Biosciences), and Alexa Fluor 488 conjugated anti-CD11b (BioLegend) antibodies. For the B220 double sort discard population, B220 positive (B220 +) cells were isolated by FACS. This primary sorted B220 + population was centrifuged at 1300 rpm for 10 min at 4 °C, the pellet re-suspended in PBS and subjected to reanalysis using the same gating schema as the primary sort. Two populations of cells on the re-analysis, those persistently positive for the B220 and those negative for the B220 (the B220 double sort discard population), were analyzed for the presence or absence of the remaining Lin + markers by flow cytometry. GR1 + cells isolated on primary sort were similarly subjected to double sorting and Lin + marker analysis as above. For stem cell marker analysis, WBM was incubated with APC-conjugated antibodies against either GR1 or B220 (BD Biosciences), and FITC-labeled anti-c-Kit (BD Biosciences), PB-labeled anti- Sca-1 (BioLegend) and PE-labeled anti-CD150 (BioLegend) antibodies. Primary sorted GR1 + cells or B220 + cells were then re-analyzed and percent stem cell marker positive cells in the different cellular populations was determined by flow cytometry.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!